Venous thromboembolism and escitalopram
- PMID: 15567215
- DOI: 10.1016/j.genhosppsych.2004.06.003
Venous thromboembolism and escitalopram
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are currently used as a first-line treatment for depression, as they have a favorable side-effect profile. Escitalopram, a new SSRI, is also well-tolerated and serious side effects are rarely associated with its use. There have been several reports that SSRIs might increase bleeding tendency in some patients by affecting platelet function. However, to our knowledge, there have been no reports about their relation to thrombosis. In this brief report, we present a case of venous thromboembolism associated with escitalopram in a patient with psychotic depression without any major risk factors for thrombosis. SSRIs might have a dual effect on platelet function. The immediate and early effect of SSRI use on platelets might be an increase be an in tendency for thrombosis, whereas the late effect after repeated dosing might be an increase in tendency to bleed, as suggested by previous literature.
Similar articles
-
Escitalopram.Drugs Today (Barc). 2004 Feb;40(2):121-31. doi: 10.1358/dot.2004.40.2.799424. Drugs Today (Barc). 2004. PMID: 15045034 Review.
-
Escitalopram: a review of its use in the management of major depressive disorder in adults.CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. CNS Drugs. 2010. PMID: 20806989 Review.
-
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.J Psychiatry Neurosci. 2006 Mar;31(2):122-31. J Psychiatry Neurosci. 2006. PMID: 16575428 Free PMC article.
-
Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy.CNS Spectr. 2006 Jun;11(6):429-32. doi: 10.1017/s1092852900014620. CNS Spectr. 2006. PMID: 16816780
-
Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.Clin Ther. 2019 Jun;41(6):1128-1138.e8. doi: 10.1016/j.clinthera.2019.04.023. Clin Ther. 2019. PMID: 31178037
Cited by
-
Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature.Front Cardiovasc Med. 2024 Jan 11;10:1133662. doi: 10.3389/fcvm.2023.1133662. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38274318 Free PMC article.
-
Escitalopram-induced epistaxis: A case report.J Taibah Univ Med Sci. 2021 Jul 8;16(6):938-942. doi: 10.1016/j.jtumed.2021.06.004. eCollection 2021 Dec. J Taibah Univ Med Sci. 2021. PMID: 34899137 Free PMC article.
-
Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.BMC Geriatr. 2023 Jun 1;23(1):344. doi: 10.1186/s12877-023-04057-z. BMC Geriatr. 2023. PMID: 37264337 Free PMC article.
-
Citalopram-associated central retinal vein occlusion.Int Ophthalmol. 2009 Aug;29(4):303-4. doi: 10.1007/s10792-008-9231-5. Epub 2008 Jun 11. Int Ophthalmol. 2009. PMID: 18545940 No abstract available.
-
Drug-induced thrombosis: an update.Drug Saf. 2013 Aug;36(8):585-603. doi: 10.1007/s40264-013-0054-6. Drug Saf. 2013. PMID: 23640658 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical